# China NMPA Drug Inspection - Guangxi Runda Pharmaceutical Co., Ltd. - Isatis root granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangxi-runda-pharmaceutical-co-ltd/3166351d-a32f-4047-a82e-99dceac65330/
Source feed: China

> China NMPA drug inspection for Guangxi Runda Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Isatis root granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangxi Runda Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Isatis root granules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangxi-runda-pharmaceutical-co-ltd/f9f7ff88-b928-40f4-95d8-640e7fabb16e/